Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethy1)-2-isopropyl-1,3-dioxolanelplatinum(II), a new platinum analogue, as an anticancer agent
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 35 (5) , 441-445
- https://doi.org/10.1007/s002800050260
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Synthesis and Antitumor Activity of a Series of [2-Substituted-4,5-bis(aminomethyl)-1,3-Dioxolane]platinum(II) ComplexesJournal of Medicinal Chemistry, 1994
- Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groupsJournal of Medicinal Chemistry, 1992
- The Therapeutic Response of a Variety of Human Tumour XenograftsPublished by Springer Nature ,1988
- MODEL FOR ESTIMATION OF CLINICALLY ACHIEVABLE PLASMA-CONCENTRATIONS FOR INVESTIGATIONAL ANTICANCER DRUGS IN MAN1986
- Preclinical studies identifying carboplatin as a viable cisplatin alternativeCancer Treatment Reviews, 1985
- Preclinical antitumor and toxicologic profile of carboplatinCancer Treatment Reviews, 1985
- High-dose cisplatin in hypertonic saline in refractory ovarian cancer.Journal of Clinical Oncology, 1985
- CisplatinAnnals of Internal Medicine, 1984
- Cisplatin — Past, Present and FuturePublished by Springer Nature ,1984
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982